跳至主要内容
临床试验/NCT01365351
NCT01365351已完成不适用

Non-interventional Study With ZOMACTON in Children With Growth Hormone Deficiency

Ferring Pharmaceuticals47 个研究点 分布在 1 个国家目标入组 1,034 人开始时间: 2007年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,034
试验地点
47
主要终点
Efficacy of ZOMACTON

研究概览

简要总结

The purpose of this study is to investigate long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner syndrome.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • therapeutic need according to SPC
  • written informed consent

排除标准

  • contraindications according to SPC

结局指标

主要结局

Efficacy of ZOMACTON

时间窗: Up to 5 years

measured by: body height, increase of body height per annum

次要结局

  • Efficacy measured by further parameters(Up to 5 years)
  • Safety of Zomacton and application device(Up to 5 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (47)

Loading locations...

相似试验

Online Surveillance of Treatment of Children With... | 临床试验